azd4635
azd4635: 1 clinical trial tracked.
azd4635 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about azd4635, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
Clinical Trial Registry Records (1)
A Multiarm, Open-label, Multicenter, Phase 1b/2 Study to Evaluate Novel Combination Therapies in Subjects With Previously Treated Advanced EGFRm NSCLC
Primary endpoint: Number of Participants With Dose-limiting Toxicities (DLTs) in Part 1
Interventionalopen43 enrolledStarted 2018-05Completion 2026-1113 sites · South Korea, Taiwan, United StatesMedImmune LLC